SE431545B - Forfarande for framstellning av nya 2-substituerade oxazolopyridiner - Google Patents

Forfarande for framstellning av nya 2-substituerade oxazolopyridiner

Info

Publication number
SE431545B
SE431545B SE7608037A SE7608037A SE431545B SE 431545 B SE431545 B SE 431545B SE 7608037 A SE7608037 A SE 7608037A SE 7608037 A SE7608037 A SE 7608037A SE 431545 B SE431545 B SE 431545B
Authority
SE
Sweden
Prior art keywords
oxazolopyridines
substituted
procedure
preparation
new
Prior art date
Application number
SE7608037A
Other languages
English (en)
Swedish (sv)
Other versions
SE7608037L (sv
Inventor
N P Jensen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7608037L publication Critical patent/SE7608037L/xx
Publication of SE431545B publication Critical patent/SE431545B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/68Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
    • C07C63/72Polycyclic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7608037A 1975-07-29 1976-07-14 Forfarande for framstellning av nya 2-substituerade oxazolopyridiner SE431545B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/600,169 US4011326A (en) 1975-07-29 1975-07-29 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents

Publications (2)

Publication Number Publication Date
SE7608037L SE7608037L (sv) 1977-01-30
SE431545B true SE431545B (sv) 1984-02-13

Family

ID=24402575

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608037A SE431545B (sv) 1975-07-29 1976-07-14 Forfarande for framstellning av nya 2-substituerade oxazolopyridiner

Country Status (14)

Country Link
US (1) US4011326A (enExample)
JP (1) JPS6037116B2 (enExample)
AU (1) AU505159B2 (enExample)
BE (1) BE844577A (enExample)
CH (1) CH603661A5 (enExample)
DE (1) DE2633905A1 (enExample)
DK (1) DK320276A (enExample)
ES (1) ES450245A1 (enExample)
FR (1) FR2319354A1 (enExample)
GB (1) GB1497985A (enExample)
HU (1) HU172167B (enExample)
NL (1) NL7607794A (enExample)
SE (1) SE431545B (enExample)
ZA (1) ZA764527B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085368Y2 (ja) * 1987-03-05 1996-02-14 日産自動車株式会社 内燃機関のコネクティングロッド
DK0937075T3 (da) * 1996-11-11 2004-04-13 Altana Pharma Ag Hidtil ukendte imidazo- og oxazolopyridiner som phosphodiesteraseinhibitorer
DE60211891T2 (de) 2001-05-15 2007-05-24 F. Hoffmann-La Roche Ag Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
JP4290648B2 (ja) * 2002-07-03 2009-07-08 エフ.ホフマン−ラ ロシュ アーゲー オキサゾール誘導体及びインスリン感作物質としてのそれらの使用
PL375779A1 (en) * 2002-08-30 2005-12-12 F.Hoffmann-La Roche Ag Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
EP1539746B1 (en) * 2002-09-12 2006-11-15 F. Hoffmann-La Roche Ag N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
MXPA05005445A (es) * 2002-11-25 2005-08-26 Hoffmann La Roche Derivados de indolilo.
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935195A (en) * 1969-04-28 1976-01-27 Sterling Drug Inc. 4,4'-Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby
FR2148362A1 (en) * 1971-08-11 1973-03-23 Ferlux 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity
AR208500A1 (es) * 1972-06-14 1977-02-15 Merck & Co Inc Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas

Also Published As

Publication number Publication date
HU172167B (hu) 1978-06-28
ES450245A1 (es) 1979-05-16
ZA764527B (en) 1978-03-29
FR2319354B1 (enExample) 1979-07-20
AU505159B2 (en) 1979-11-08
NL7607794A (nl) 1977-02-01
SE7608037L (sv) 1977-01-30
DE2633905A1 (de) 1977-02-17
GB1497985A (en) 1978-01-12
JPS6037116B2 (ja) 1985-08-24
AU1605276A (en) 1978-01-26
US4011326A (en) 1977-03-08
JPS5217495A (en) 1977-02-09
BE844577A (fr) 1977-01-28
DK320276A (da) 1977-01-30
CH603661A5 (enExample) 1978-08-31
FR2319354A1 (fr) 1977-02-25

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7513571L (sv) Forfarande for framstellning av nya substituerade pyridiner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE431545B (sv) Forfarande for framstellning av nya 2-substituerade oxazolopyridiner
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE435716B (sv) Forfarande for framstellning av nya penicilliner
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE409868B (sv) Forfarande for framstellning av nya triaminoandrostaner
SE420730B (sv) Analogiforfarande for framstellning av nya pentacykliska foreningar
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE431979B (sv) Forfarande for framstellning av nya omega-aminoalkansyraarylamider
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE434952B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE427558B (sv) Analogiforfarande for framstellning av 7-metoxicefalosporinderivat
SE7603682L (sv) Forfarande for framstellning av en eteriskt substituerad monosackarid

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7608037-3

Effective date: 19920210

Format of ref document f/p: F